NCT04585412View on ClinicalTrials.gov

Evaluate Bioequivalence of Palonosetron (0.25mg/5mL)

PHASE4CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

August 17, 2020

Primary Completion Date

October 24, 2020

Study Completion Date

December 31, 2020

Conditions
Chemotherapy-induced Nausea and Vomiting, Prophylaxis
Interventions
DRUG

Palonosetron

Pharmacokinetic study under fasting conditions

Trial Locations (1)

Unknown

Taichung Veterans General Hospital, Taichung

All Listed Sponsors
lead

Yung Shin Pharm. Ind. Co., Ltd.

INDUSTRY

NCT04585412 - Evaluate Bioequivalence of Palonosetron (0.25mg/5mL) | Biotech Hunter | Biotech Hunter